Over 10 years we help companies reach their financial and branding goals. Maxbizz is a values-driven consulting agency dedicated.

Gallery

Contact

+1-800-456-478-23

411 University St, Seattle

maxbizz@mail.com

the street news image

PaaSoo Technology (Ireland) Expands To Japan

DUBLIN, Sept. 30, 2021 /PRNewswire/ — PaaSoo Technology ( Ireland) Limited, a leading provider of global cloud communication services, has announced its expansion into Japan. PaaSoo has already developed strong cooperation with major Japanese mobile Internet companies and Telecom operators for delivering worldwide coverage for SMS and Voice communications to enterprise customers from Japan and…

Powell: “Tension” between jobs, inflation is the chief challenge facing Fed

Powell: “Tension” between jobs, inflation is the chief challenge facing Fed

© Reuters. FILE PHOTO: Federal Reserve Chairman Jerome Powell testifies during a Senate Banking, Housing and Urban Affairs Committee hearing on the CARES Act, at the Hart Senate Office Building in Washington, DC, U.S., September 28, 2021. Kevin Dietsch/Pool via REUT By Howard Schneider (Reuters) -Resolving “tension” between high inflation and still-elevated unemployment is the…

Mastercard rolls out new program

Mastercard rolls out new program

Mastercard unveiled on Tuesday a buy now, pay later (BNPL) program that will allow consumers to pay for online and in-store purchases through equal and interest-free installments.The Mastercard Installments program will be available in markets across the United States, the United Kingdom and Australia, the company said.Mastercard says its Installments program builds on Mastercard’s investments…

the street news image

Third ADC With Synaffix’s Technology Enters Clinical Development

AMSTERDAM, Sept. 29, 2021 /PRNewswire/ — Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announces that its partner Shanghai Miracogen has commenced a Phase I trial in the US with MRG004A, an ADC designed to treat solid tumors.  This is…